I guess what I said is that I think it's most important that Canada maintain our investment in innovation and research and development. That is where people with Alzheimer's disease and people who are affected with neurological disorders.... It has the least success rate in terms of having drugs that treat the disease and will cure the disease. We're looking for equitable access for Canadians to the same drugs that are available in those markets, and the comparable ability to promote and support our investment in research and development and innovation in Canada, so that it doesn't leave Canada.
I also talked about the Alzheimer Society's investment in research. We feel very strongly about the investment we have made in research, which has been based on the donations of ordinary Canadians over the last 30 years. That's how we fund research at our society. We feel very strongly that our investment is at risk if innovation is not encouraged to the same extent in Canada that it is in the EU and the U.S. We're afraid that those researchers we support, and that we want to support, those young researchers that we want to bring along and are going to help us find the causes and cures of this disease, will leave Canada, because there will be better fields afar in other countries for them to do their research.